Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| H&R BLOCK INCHRB · Entity 533 | Director | September 10, 2020 | September 14, 2020 |
| STERIS plcSTE · Entity 3228 | Director | July 21, 2021 | July 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
H&R BLOCK INC
Report date September 10, 2020 · Filed September 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 113,969.162 |
Reported balance
After 2020-09-10 transaction · row 1
1 source rowRow 1 · 2020-09-10 · Grant · Acquired 10,053 · Balance 113,969.162 F1: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2018 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2018 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director.
STERIS plc
Report date July 21, 2021 · Filed July 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 8,245 |
Reported balance
After 2021-07-21 transaction · row 1
1 source rowRow 1 · 2021-07-21 · Grant · Acquired 1,561 · Balance 8,245 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03 | Direct | 0 |
Reported balance
After 2021-07-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-07-21 · Exercise / conversion · Acquired 1,561 · Balance 0 F1: This option is part of an option to purchase 3,121 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. |
Filing footnotes · ownership attribution and instrument terms
F1: This option is part of an option to purchase 3,121 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 6,684 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.34 · Expires 2020-08-04 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,133 · Balance 0 F2: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 3,121 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.36 · Expires 2022-08-03 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 3,218 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 927 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 436 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 13,996 · Balance 0 F7: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F2: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2021 Filed Jul 22, 2021 16:36 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,561 | $0.00 Strike: $31.61 | $0.00 |
DisclosureSEC source: 0001209191-21-047755 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,561 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is part of an option to purchase 3,121 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 16:36 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,561 | $31.61 | $49,343.21 |
DisclosureSEC source: 0001209191-21-047755 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,245 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,560 | $0.00 Strike: $31.61 | $0.00 |
DisclosureSEC source: 0001209191-20-061181 · doc4.xml · derivative · entry 3 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,561 Underlying: Ordinary Shares · 1,560 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is part of an option to purchase 3,121 STERIS ordinary shares, which is fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,560 | $193.79 | $302,312.40 |
DisclosureSEC source: 0001209191-20-061181 · doc4.xml · nonDerivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,684 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $193.75 to $193.8033 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 1,560 | $31.61 | $49,311.60 |
DisclosureSEC source: 0001209191-20-061181 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 20:38 UTC | H&R BLOCK INC HRB · Entity 533 | GrantCommon Stock | 10,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011486 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,969.162 F1 · shares: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2018 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 16:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045477 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,170 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board Service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 16:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 519 | $158.00 | $82,002.00 |
DisclosureSEC source: 0001209191-20-045477 · doc4.xml · derivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,854 Underlying: Ordinary Shares · 519 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board Service. F3 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:32 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,133 | $0.00 Strike: $32.34 | $0.00 |
DisclosureSEC source: 0001209191-20-009209 · doc4.xml · derivative · entry 3 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:32 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,133 | $166.67 | $522,162.70 |
DisclosureSEC source: 0001209191-20-009209 · doc4.xml · nonDerivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,684 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:32 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 3,133 | $32.34 | $101,321.22 |
DisclosureSEC source: 0001209191-20-009209 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 20:33 UTC | H&R BLOCK INC HRB · Entity 533 | GrantCommon Stock | 6,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-012545 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,401.827 F1 · shares: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2018 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 16:33 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045117 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,335 Underlying: Ordinary Shares · 1,339 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 16:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 119 | $0.00 Strike: $152.32 | $0.00 |
DisclosureSEC source: 0001209191-19-045117 · doc4.xml · derivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119 Underlying: Ordinary Shares · 119 shares Expires 2029-08-06 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 13,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 7 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,996 Underlying: Ordinary Shares · 13,996 shares Expires not disclosed F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 6 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F6 · price: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 927 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 5 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F5 · price: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 4 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F4 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 3 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F3 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F2 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 15:33 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 6,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021604 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,684 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerCareer Restricted Stock Units · Derivative | 13,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · derivative · entry 7 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,996 shares Expires not disclosed F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · derivative · entry 6 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F6 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 927 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · derivative · entry 5 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F5 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · derivative · entry 4 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · derivative · entry 3 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F3 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F3 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F2 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F2 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:57 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 6,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021562 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 20:34 UTC | H&R BLOCK INC HRB · Entity 533 | GrantCommon Stock | 5,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-013478 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,972.481 F1 · shares: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2018 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:24 UTC | STERIS plc STE · Entity 158792 | GrantCareer Restricted Stock Units · Derivative | 1,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046228 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,996 Underlying: Ordinary Shares · 1,634 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:24 UTC | STERIS plc STE · Entity 158792 | GrantDirector Stock Option (right to buy) · Derivative | 436 | $0.00 Strike: $114.74 | $0.00 |
DisclosureSEC source: 0001209191-18-046228 · doc4.xml · derivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 20:33 UTC | H&R BLOCK INC HRB · Entity 533 | GrantCommon Stock | 5,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015064 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,339.851 F1 · shares: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2013 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:31 UTC | STERIS plc STE · Entity 158792 | GrantCareer Restricted Stock Units · Derivative | 1,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048601 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,362 Underlying: Ordinary Shares · 1,797 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:31 UTC | STERIS plc STE · Entity 158792 | GrantDirector Stock Option (right to buy) · Derivative | 927 | $0.00 Strike: $86.23 | $0.00 |
DisclosureSEC source: 0001209191-17-048601 · doc4.xml · derivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 20:32 UTC | H&R BLOCK INC HRB · Entity 533 | Exercise / conversionCall Option to Purchase · Derivative | 8,000 | $0.00 Strike: $23.37 | $0.00 |
DisclosureSEC source: 0001225208-17-011514 · doc4.xml · derivative · entry 3 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2017-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 20:32 UTC | H&R BLOCK INC HRB · Entity 533 | SaleCommon Stock | 8,000 | $30.01 | $240,080.00 |
DisclosureSEC source: 0001225208-17-011514 · doc4.xml · nonDerivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,083.248 F1 · price: The price used is a weighted average of prices within the range of $29.960 to $30.100. The reporting person will provide full details of the price information reported upon a request from the Commission or any shareholder. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 20:32 UTC | H&R BLOCK INC HRB · Entity 533 | Exercise / conversionCommon Stock | 8,000 | $23.37 | $186,960.00 |
DisclosureSEC source: 0001225208-17-011514 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,083.248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 20:32 UTC | H&R BLOCK INC HRB · Entity 533 | GrantCommon Stock | 6,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039197 · doc4.xml · nonDerivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,101.735 F1 · shares: Deferred stock units (DSUs) granted under the H&R Block, Inc. 2013 Long Term Incentive Plan. DSUs are fully vested on the grant date and are not subject to forfeiture. Vested DSUs become payable in shares of common stock on the six-month anniversary date of termination of service as a director. F2 · balance_after: Represents DSUs and shares of common stock. DSUs and shares of common stock were previously reported separately, but are reported on a combined basis in this report and will be reported on this combined basis in future reports. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.